Verified Nov 2026
Other
·

Morristown, New Jersey
·
Since 2018
Averitas Pharma is a specialty pharmaceutical company headquartered in Morristown, New Jersey, founded in 2018 as the U.S. commercial subsidiary of the Grünenthal Group. With 100–200 employees and revenue under $10 million, the company develops non-opioid pain management treatments. Its flagship product, QUTENZA® (capsaicin) 8% topical system, is FDA-approved for neuropathic pain associated with postherpetic neuralgia and diabetic peripheral neuropathy of the feet.
Averitas Pharma at a glance
Revenue
<$10M
Est. band
Employees
100-200
Founded
2018
Headquarters
Morristown, New Jersey
Industries
Automotive
Electric Vehicles
Medical
Overview
Averitas Pharma is a specialty pharmaceutical company headquartered in Morristown, New Jersey, founded in 2018 as the U.S. commercial subsidiary of the Grünenthal Group. With 100–200 employees and revenue under $10 million, the company develops non-opioid pain management treatments. Its flagship product, QUTENZA® (capsaicin) 8% topical system, is FDA-approved for neuropathic pain associated with postherpetic neuralgia and diabetic peripheral neuropathy of the feet.
At a glance
Attribute | Detail |
|---|---|
Founded | 2018 |
Headquarters | Morristown, New Jersey |
Employees | 100-200 |
Revenue | <$10M (estimated) |
What Averitas Pharma makes
The company markets an FDA-approved topical analgesic system targeting neuropathic pain conditions and provides clinical and safety information to healthcare providers and patients.
Latest developments
2026-05-03 — Grünenthal acquires Averitas Pharma and establishes commercial footprint in the US - O-STA (o-sta.si)
2026-01-29 — Bringing experience across market access, training, and field leadership, Tam Parker joined Averitas as a Regional Business Director with a passion to help make a difference for an underserved patient community suffering … | Averitas Pharma (linkedin.com)
2025-09-24 — 36F79725D0245 — 6505--Averitas Pharma, Inc., 65IB, 36F79725D0245 Performance Peri | SAM Directory (sam.directory)
2025-09-23 — Averitas Pharma Appoints Gunjan Aggarwal as Head of Data and Analytics - CDO Magazine (cdomagazine.tech)
2025-09-22 — Kudos and Averitas Pharma collaborate to improve access to scientific content for US healthcare professionals (knowledgespeak.com)
Company details
Averitas Pharma operates within the medical and specialty pharmaceutical sectors, serving patients with chronic pain conditions requiring non-opioid therapeutic options. Averitas Pharma was founded in 2018, has an estimated 100-200 employees, and is headquartered in Morristown, New Jersey.
Frequently asked questions
What does Averitas Pharma do?
Averitas Pharma is a specialty pharmaceutical company headquartered in Morristown, New Jersey, founded in 2018 as the U.S. commercial subsidiary of the Grünenthal Group. With 100–200 employees and revenue under $10 million, the company develops non-opioid pain management treatments. Its flagship product, QUTENZA® (capsaicin) 8% topical system, is FDA-approved for neuropathic pain associated with postherpetic neuralgia and diabetic peripheral neuropathy of the feet.
Where is Averitas Pharma headquartered?
Averitas Pharma is headquartered in Morristown, New Jersey (360 Mount Kemble Avenue, Morristown, New Jersey, 07960).
When was Averitas Pharma founded?
Averitas Pharma was founded in 2018.
How big is Averitas Pharma?
Averitas Pharma has an estimated 100-200 employees, with revenue in the <$10M range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
